Elan Announces Transactions: Decisively Transforming the Company
Monday, May 20, 2013
Upon shareholder approval, the totality of these strategically driven decisions will form a dynamic and unique business foundation for Elan in the years ahead.

Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
Monday, May 20, 2013
The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment.

GE Scientists in Technology “Relay Race” Against Cancer
Monday, May 20, 2013
GE technologies being developed to impact every stage of cancer patient care from screening to treatment and monitoring.

Aeolus Strengthens Board of Directors
Monday, May 20, 2013
Aeolus Pharmaceuticals, Inc. announced the appointment of John M. Clerici, Mitchell D. Kaye, and Jeffrey A. Scott, M.D., to its board of directors.

New £23m Research Unit will use Advances in Genetics to Help Reduce Risk of Disease
Monday, May 20, 2013
Unit will exploit the latest advances in genetics to improve understanding of how changes to lifestyle or environment can reduce the risk of disease.

Curie-Cancer and Roche Strengthen Partnership
Friday, May 17, 2013
Curie-Cancer and Roche build on four years partnership by increasing translational research programs, speeding up development of new cancer treatments.

Algeta: FDA Approves Xofigo (radium-223 dichloride)
Friday, May 17, 2013
Xofigo shown in a pivotal phase III trial to significantly improve overall survival.

<<	1 2 3 4 5 6 7	>>
Showing Results 11 - 20 of 7860